CONMED Corp — Director's Dealing 2022

Aug 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-08-12

Reporting Person: Peters Stanley W III (VP GM Advanced Surgery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-12	Common Stock	M	7500	$41.93	Acquired	7563	Direct
2022-08-12	Common Stock	S	7500	$100.90	Disposed	63	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-12	Options To Purchase Common Stock	$41.93	M	7500	Disposed	2027-03-01	Common Stock (7500)	Direct

Footnotes

F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.